ANAVEX LIFE SCIENCES CORP. Stock-Based Compensation
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Stock-Based Compensation of -$17.08 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was -$17.08M, a 495.10% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $314.00K, a 78.33% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.11M, a 46.13% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $3.72M, a 84.85% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. share-based payment arrangement, noncash expense for fiscal 2025 was $11.55M, a 22.37% increase from fiscal 2024.
- ANAVEX LIFE SCIENCES CORP. share-based payment arrangement, noncash expense for fiscal 2024 was $9.44M, a 42.35% decline from fiscal 2023.
- ANAVEX LIFE SCIENCES CORP. share-based payment arrangement, noncash expense for fiscal 2023 was $16.37M, a 10.93% decline from fiscal 2022.
- ANAVEX LIFE SCIENCES CORP. share-based payment arrangement, noncash expense for fiscal 2022 was $18.38M, a 123.29% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed | Share-based Payment Arrangement, Noncash Expense 89 month | Share-based Payment Arrangement, Noncash Expense 92 month | Share-based Payment Arrangement, Noncash Expense 95 month | Share-based Payment Arrangement, Noncash Expense 98 month | Share-based Payment Arrangement, Noncash Expense 101 month | Share-based Payment Arrangement, Noncash Expense 104 month | Share-based Payment Arrangement, Noncash Expense 107 month | Share-based Payment Arrangement, Noncash Expense 110 month | Share-based Payment Arrangement, Noncash Expense 113 month | Share-based Payment Arrangement, Noncash Expense 116 month | Share-based Payment Arrangement, Noncash Expense 119 month | Share-based Payment Arrangement, Noncash Expense 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$17.08M 10-Q · filed 2026-08-28 | -$16.77M derived: sum of 2 quarters · filed 2026-08-28 | -$15.66M 10-Q · filed 2026-08-28 | -$11.94M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2026-03-31 | $314.00K 10-Q · filed 2026-08-28 | $1.42M 10-Q · filed 2026-08-28 | $5.14M derived: sum of 3 quarters · filed 2026-08-28 | $9.47M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2025-12-31 | $1.11M 10-Q · filed 2026-02-09 | $4.83M derived: sum of 2 quarters · filed 2026-08-28 | $9.15M derived: sum of 3 quarters · filed 2026-08-28 | $10.60M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2025-09-30 | $3.72M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $8.04M derived: sum of 2 quarters · filed 2026-08-28 | $9.49M derived: sum of 3 quarters · filed 2026-08-28 | $11.55M 10-K/A · filed 2026-08-28 | ||||||||||||||||
| 2025-06-30 | $4.32M 10-Q · filed 2026-08-28 | $5.77M derived: sum of 2 quarters · filed 2026-08-28 | $7.83M 10-Q · filed 2026-08-28 | $9.84M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2025-03-31 | $1.45M 10-Q · filed 2026-08-28 | $3.50M 10-Q · filed 2026-08-28 | $5.52M derived: sum of 3 quarters · filed 2026-08-28 | $8.01M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2024-12-31 | $2.06M 10-Q · filed 2026-02-09 | $4.07M derived: sum of 2 quarters · filed 2026-08-28 | $6.56M derived: sum of 3 quarters · filed 2026-08-28 | $9.21M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2024-09-30 | $2.01M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $4.50M derived: sum of 2 quarters · filed 2026-08-28 | $7.15M derived: sum of 3 quarters · filed 2026-08-28 | $9.44M 10-K/A · filed 2026-08-28 | ||||||||||||||||
| 2024-06-30 | $2.49M 10-Q · filed 2025-08-12 | $5.14M derived: sum of 2 quarters · filed 2025-08-12 | $7.42M 10-Q · filed 2025-08-12 | $10.61M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2024-03-31 | $2.65M 10-Q · filed 2025-05-13 | $4.94M 10-Q · filed 2025-05-13 | $8.13M derived: sum of 3 quarters · filed 2026-08-28 | $11.99M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2023-12-31 | $2.29M 10-Q · filed 2025-02-12 | $5.47M derived: sum of 2 quarters · filed 2026-08-28 | $9.34M derived: sum of 3 quarters · filed 2026-08-28 | $13.31M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2023-09-30 | $3.19M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $7.05M derived: sum of 2 quarters · filed 2026-08-28 | $11.02M derived: sum of 3 quarters · filed 2026-08-28 | $16.37M 10-K/A · filed 2026-08-28 | ||||||||||||||||
| 2023-06-30 | $3.87M 10-Q · filed 2024-08-06 | $7.84M derived: sum of 2 quarters · filed 2024-08-06 | $13.18M 10-Q · filed 2024-08-06 | $13.18M 10-Q · filed 2023-08-08 | $19.23M derived: sum of 4 quarters · filed 2024-08-06 | |||||||||||||||
| 2023-03-31 | $3.97M 10-Q · filed 2024-05-09 | $9.32M 10-Q · filed 2024-05-09 | $9.32M 10-Q · filed 2023-05-09 | $15.36M derived: sum of 3 quarters · filed 2024-05-09 | $19.35M derived: sum of 4 quarters · filed 2024-05-09 | |||||||||||||||
| 2022-12-31 | $5.35M 10-Q · filed 2024-02-07 | $5.35M 10-Q · filed 2023-02-07 | $11.39M derived: sum of 2 quarters · filed 2024-02-07 | $15.38M derived: sum of 3 quarters · filed 2024-02-07 | $19.82M derived: sum of 4 quarters · filed 2024-02-07 | |||||||||||||||
| 2022-09-30 | $6.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $10.03M derived: sum of 2 quarters · filed 2023-11-27 | $14.47M derived: sum of 3 quarters · filed 2023-11-27 | $18.38M 10-K · filed 2023-11-27 | $18.38M 10-K · filed 2022-11-28 | |||||||||||||||
| 2022-06-30 | $3.99M 10-Q · filed 2022-08-09 | $8.43M derived: sum of 2 quarters · filed 2022-08-09 | $12.34M 10-Q · filed 2023-08-08 | $15.49M derived: sum of 4 quarters · filed 2023-11-27 | ||||||||||||||||
| 2022-03-31 | $4.44M 10-Q · filed 2022-05-10 | $8.35M 10-Q · filed 2023-05-09 | $11.50M derived: sum of 3 quarters · filed 2023-11-27 | $13.79M derived: sum of 4 quarters · filed 2023-11-27 | ||||||||||||||||
| 2021-12-31 | $3.91M 10-Q · filed 2023-02-07 | $7.06M derived: sum of 2 quarters · filed 2023-11-27 | $9.35M derived: sum of 3 quarters · filed 2023-11-27 | $11.20M derived: sum of 4 quarters · filed 2023-11-27 | ||||||||||||||||
| 2021-09-30 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $5.45M derived: sum of 2 quarters · filed 2023-11-27 | $7.29M derived: sum of 3 quarters · filed 2023-11-27 | $8.23M 10-K · filed 2023-11-27 | $8.23M 10-K · filed 2021-11-24 | |||||||||||||||
| 2021-06-30 | $2.29M 10-Q · filed 2022-08-09 | $4.14M derived: sum of 2 quarters · filed 2022-08-09 | $5.08M 10-Q · filed 2022-08-09 | $5.74M derived: sum of 4 quarters · filed 2022-11-28 | ||||||||||||||||
| 2021-03-31 | $1.85M 10-Q · filed 2022-05-10 | $2.79M 10-Q · filed 2022-05-10 | $3.45M derived: sum of 3 quarters · filed 2022-11-28 | $4.70M derived: sum of 4 quarters · filed 2022-11-28 | ||||||||||||||||
| 2020-12-31 | $939.31K 10-Q · filed 2022-02-09 | $1.60M derived: sum of 2 quarters · filed 2022-11-28 | $2.85M derived: sum of 3 quarters · filed 2022-11-28 | $4.55M derived: sum of 4 quarters · filed 2022-11-28 | ||||||||||||||||
| 2020-09-30 | $660.60K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $1.91M derived: sum of 2 quarters · filed 2022-11-28 | $3.61M derived: sum of 3 quarters · filed 2022-11-28 | $4.88M 10-K · filed 2022-11-28 | ||||||||||||||||
| 2020-06-30 | $1.25M 10-Q · filed 2021-08-12 | $2.95M derived: sum of 2 quarters · filed 2021-08-12 | $4.22M 10-Q · filed 2021-08-12 | $5.45M derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||||||||
| 2020-03-31 | $1.70M 10-Q · filed 2021-05-13 | $2.97M 10-Q · filed 2021-05-13 | $4.20M derived: sum of 3 quarters · filed 2021-05-13 | $5.44M derived: sum of 4 quarters · filed 2021-05-13 | ||||||||||||||||
| 2019-12-31 | $1.26M 10-Q · filed 2021-02-16 | $2.50M derived: sum of 2 quarters · filed 2021-02-16 | $3.74M derived: sum of 3 quarters · filed 2021-02-16 | $5.63M derived: sum of 4 quarters · filed 2021-02-16 | ||||||||||||||||
| 2019-09-30 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | $2.47M derived: sum of 2 quarters · filed 2020-12-28 | $4.36M derived: sum of 3 quarters · filed 2020-12-28 | $6.43M 10-K · filed 2020-12-28 | ||||||||||||||||
| 2019-06-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-06 | $3.13M derived: sum of 2 quarters · filed 2020-08-06 | $5.19M 10-Q · filed 2020-08-06 | $6.69M derived: sum of 4 quarters · filed 2020-08-06 | ||||||||||||||||
| 2019-03-31 | $1.89M 10-Q · filed 2020-05-07 | $3.96M 10-Q · filed 2020-05-07 | $5.45M derived: sum of 3 quarters · filed 2020-05-07 | $7.13M derived: sum of 4 quarters · filed 2020-05-07 | ||||||||||||||||
| 2018-12-31 | $2.07M 10-Q · filed 2020-02-06 | $3.56M derived: sum of 2 quarters · filed 2020-02-06 | $5.24M derived: sum of 3 quarters · filed 2020-02-06 | $6.46M derived: sum of 4 quarters · filed 2020-02-06 | ||||||||||||||||
| 2018-09-30 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $3.17M derived: sum of 2 quarters · filed 2019-12-16 | $4.40M derived: sum of 3 quarters · filed 2019-12-16 | $5.52M 10-K · filed 2019-12-16 | ||||||||||||||||
| 2018-06-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-07 | $2.90M derived: sum of 2 quarters · filed 2019-08-07 | $4.03M 10-Q · filed 2019-08-07 | $5.14M derived: sum of 4 quarters · filed 2019-08-07 | ||||||||||||||||
| 2018-03-31 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-09 | $2.35M 10-Q · filed 2019-05-09 | $3.47M derived: sum of 3 quarters · filed 2019-05-09 | $4.63M derived: sum of 4 quarters · filed 2019-05-09 | ||||||||||||||||
| 2017-12-31 | $1.12M 10-Q · filed 2019-02-07 | $2.24M derived: sum of 2 quarters · filed 2019-02-07 | $3.40M derived: sum of 3 quarters · filed 2019-02-07 | $4.37M derived: sum of 4 quarters · filed 2019-02-07 | ||||||||||||||||
| 2017-09-30 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $2.28M derived: sum of 2 quarters · filed 2019-01-25 | $3.25M derived: sum of 3 quarters · filed 2019-01-25 | $4.14M 10-K · filed 2019-01-25 | ||||||||||||||||
| 2017-06-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09 | $2.13M derived: sum of 2 quarters · filed 2018-08-09 | $3.02M 10-Q · filed 2018-08-09 | $6.80M derived: sum of 4 quarters · filed 2019-01-25 | ||||||||||||||||
| 2017-03-31 | $968.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-10 | $1.86M 10-Q · filed 2018-05-10 | $5.64M derived: sum of 3 quarters · filed 2019-01-25 | $5.87M derived: sum of 4 quarters · filed 2019-01-25 | ||||||||||||||||
| 2016-12-31 | $889.27K 10-Q · filed 2018-02-07 | $4.67M derived: sum of 2 quarters · filed 2019-01-25 | $4.90M derived: sum of 3 quarters · filed 2019-01-25 | $5.13M derived: sum of 4 quarters · filed 2019-01-25 | ||||||||||||||||
| 2016-09-30 | $3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $4.01M derived: sum of 2 quarters · filed 2019-01-25 | $4.24M derived: sum of 3 quarters · filed 2019-01-25 | $5.06M 10-K · filed 2019-01-25 | ||||||||||||||||
| 2016-06-30 | $228.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-07 | $450.95K derived: sum of 2 quarters · filed 2017-08-07 | $1.28M 10-Q · filed 2017-08-07 | $2.65M derived: sum of 4 quarters · filed 2017-12-11 | ||||||||||||||||
| 2016-03-31 | $222.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | $1.05M 10-Q · filed 2017-05-10 | $2.42M derived: sum of 3 quarters · filed 2017-12-11 | $2.65M derived: sum of 4 quarters · filed 2017-12-11 | ||||||||||||||||
| 2015-12-31 | $826.02K 10-Q · filed 2017-02-07 | $2.19M derived: sum of 2 quarters · filed 2017-12-11 | $2.43M derived: sum of 3 quarters · filed 2017-12-11 | $2.44M derived: sum of 4 quarters · filed 2017-12-11 | ||||||||||||||||
| 2015-09-30 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $1.60M derived: sum of 2 quarters · filed 2017-12-11 | $1.62M derived: sum of 3 quarters · filed 2017-12-11 | $1.63M 10-K · filed 2017-12-11 | ||||||||||||||||
| 2015-06-30 | $233.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-11 | $250.09K derived: sum of 2 quarters · filed 2016-08-11 | $265.46K 10-Q · filed 2016-08-11 | $893.79K derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||||||
| 2015-03-31 | $16.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-11 | $31.54K 10-Q · filed 2016-05-11 | $659.88K derived: sum of 3 quarters · filed 2016-12-14 | $669.47K derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||||||
| 2014-12-31 | $15.36K 10-Q · filed 2016-02-08 | $643.70K derived: sum of 2 quarters · filed 2016-12-14 | $653.29K derived: sum of 3 quarters · filed 2016-12-14 | $653.29K derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||||||
| 2014-09-30 | $628.34K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | $637.92K derived: sum of 2 quarters · filed 2016-12-14 | $637.92K derived: sum of 3 quarters · filed 2016-12-14 | $637.92K 10-K · filed 2016-12-14 | ||||||||||||||||
| 2014-06-30 | $9.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-14 | $9.59K derived: sum of 2 quarters · filed 2015-08-14 | $9.59K 10-Q · filed 2015-08-14 | $1.01M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||||||
| 2014-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-14 | $0.00 10-Q · filed 2015-05-14 | $1.00M derived: sum of 3 quarters · filed 2015-05-14 | $1.00M derived: sum of 4 quarters · filed 2015-05-14 | $5.85M 10-Q/A · filed 2014-05-30 | |||||||||||||||
| 2013-12-31 | $0.00 10-Q · filed 2015-02-17 | $1.00M derived: sum of 2 quarters · filed 2015-02-17 | $1.00M derived: sum of 3 quarters · filed 2015-02-17 | $1.00M derived: sum of 4 quarters · filed 2015-02-17 | $5.85M 10-Q · filed 2014-02-14 | |||||||||||||||
| 2013-09-30 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | $1.00M derived: sum of 2 quarters · filed 2014-12-29 | $1.00M derived: sum of 3 quarters · filed 2014-12-29 | $1.00M 10-K · filed 2014-12-29 | $5.85M 10-K · filed 2013-12-30 | |||||||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2014-08-13 | $0.00 derived: sum of 2 quarters · filed 2014-08-13 | $0.00 10-Q · filed 2014-08-13 | $0.00 derived: sum of 4 quarters · filed 2014-08-13 | $4.84M 10-Q · filed 2013-08-14 | |||||||||||||||
| 2013-03-31 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2014-05-30 | $0.00 10-Q/A · filed 2014-05-30 | $0.00 derived: sum of 3 quarters · filed 2014-05-30 | $98.80K derived: sum of 4 quarters · filed 2014-05-30 | $4.84M 10-Q · filed 2013-05-17 | |||||||||||||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-14 | $0.00 derived: sum of 2 quarters · filed 2014-02-14 | $98.80K derived: sum of 3 quarters · filed 2014-02-14 | $178.94K derived: sum of 4 quarters · filed 2014-02-14 | $4.84M 10-Q · filed 2013-02-14 | |||||||||||||||
| 2012-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $98.80K derived: sum of 2 quarters · filed 2013-12-30 | $178.94K derived: sum of 3 quarters · filed 2013-12-30 | $302.21K 10-K · filed 2013-12-30 | $4.84M 10-K · filed 2012-12-31 | |||||||||||||||
| 2012-06-30 | $98.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-14 | $178.94K derived: sum of 2 quarters · filed 2013-08-14 | $302.21K 10-Q · filed 2013-08-14 | $559.96K derived: sum of 4 quarters · filed 2013-08-14 | $4.84M 10-Q · filed 2012-08-17 | |||||||||||||||
| 2012-03-31 | $80.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-17 | $203.41K 10-Q · filed 2013-05-17 | $461.15K derived: sum of 3 quarters · filed 2013-05-17 | $620.34K derived: sum of 4 quarters · filed 2013-05-17 | $4.74M 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | $123.26K 10-Q · filed 2013-02-14 | $381.01K derived: sum of 2 quarters · filed 2013-02-14 | $540.20K derived: sum of 3 quarters · filed 2013-02-14 | $1.21M derived: sum of 4 quarters · filed 2013-02-14 | $4.66M 10-Q · filed 2012-02-14 | |||||||||||||||
| 2011-09-30 | $257.75K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | $416.93K derived: sum of 2 quarters · filed 2012-12-31 | $1.09M derived: sum of 3 quarters · filed 2012-12-31 | $1.27M 10-K · filed 2012-12-31 | $4.54M 10-K · filed 2011-12-22 | |||||||||||||||
| 2011-06-30 | $159.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-17 | $827.66K derived: sum of 2 quarters · filed 2012-08-17 | $1.02M 10-Q · filed 2012-08-17 | $1.16M derived: sum of 4 quarters · filed 2012-08-17 | $4.28M 10-Q · filed 2011-08-12 | |||||||||||||||
| 2011-03-31 | $668.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | $856.23K 10-Q · filed 2012-05-15 | $1.00M derived: sum of 3 quarters · filed 2012-05-15 | |||||||||||||||||
| 2010-12-31 | $187.75K 10-Q · filed 2012-02-14 | $333.67K derived: sum of 2 quarters · filed 2012-02-14 | ||||||||||||||||||
| 2010-09-30 | $145.92K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-22 | $770.05K 10-K · filed 2011-12-22 | ||||||||||||||||||
| 2010-06-30 | $624.14K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |